Evidence map›Paper›PMID 39694825›Full record

ReviewRNA (New York, N.Y.)2025

RNA-binding proteins in disease etiology: fragile X syndrome and spinal muscular atrophy.

Gideon Dreyfuss

Abstract readReview
In one paragraph

Review in RNA (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gideon DreyfussDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA gdreyfuss@hhmi.upenn.edu.

Funding

Mechanism and Regulation of U1 snRNP TelescriptingR35GM139646 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DREYFUSS, GIDEON · 2021 to 2025
$2.4M
NIGMS NIH HHS R35 GM139646
6 · The paper itself

Abstract

All RNAs exist in complexes (RNPs) with RNA-binding proteins (RBPs). Studies in my lab since the 1980s have identified, sequenced and characterized the major pre-mRNA- and mRNA-RBPs (hnRNPs/mRNPs), revealing RNA-binding domains and common features of numerous RBPs and their central roles in posttranscriptional gene regulation. The first links between RBPs and RNPs to diseases emerged serendipitously for fragile X syndrome, as its gene (

Indexed as

Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeMuscular Atrophy, SpinalRNA-Binding ProteinsAnimalsHumansSMN Complex ProteinsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1RNA-Binding ProteinsSMN Complex Proteins

Identifiers

PMID39694825
PMCPMC11874976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.